English
简体中文
Total: £ 56.28
Published Date: 2025-11-19 | Pages: 121 | Tables: 111 | Pharma & Healthcare
The global market for Ranitidine (Zantac) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Ranitidine (Zantac) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ranitidine (Zantac) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Ranitidine (Zantac) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Ranitidine (Zantac) include Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international), Geri-Care Pharmaceuticals, PAI Holdings, LLC, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Ranitidine (Zantac), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ranitidine (Zantac) by region & country, by Type, and by Application.
The Ranitidine (Zantac) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranitidine (Zantac).
Market Segmentation
By Company
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
Segment by Type
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ranitidine (Zantac) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ranitidine (Zantac) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ranitidine (Zantac) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Ranitidine (Zantac) Product Introduction
1.2 Global Ranitidine (Zantac) Market Size Forecast
1.2.1 Global Ranitidine (Zantac) Sales Value (2020-2031)
1.2.2 Global Ranitidine (Zantac) Sales Volume (2020-2031)
1.2.3 Global Ranitidine (Zantac) Sales Price (2020-2031)
1.3 Ranitidine (Zantac) Market Trends & Drivers
1.3.1 Ranitidine (Zantac) Industry Trends
1.3.2 Ranitidine (Zantac) Market Drivers & Opportunity
1.3.3 Ranitidine (Zantac) Market Challenges
1.3.4 Ranitidine (Zantac) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ranitidine (Zantac) Players Revenue Ranking (2024)
2.2 Global Ranitidine (Zantac) Revenue by Company (2020-2025)
2.3 Global Ranitidine (Zantac) Players Sales Volume Ranking (2024)
2.4 Global Ranitidine (Zantac) Sales Volume by Company Players (2020-2025)
2.5 Global Ranitidine (Zantac) Average Price by Company (2020-2025)
2.6 Key Manufacturers Ranitidine (Zantac) Manufacturing Base and Headquarters
2.7 Key Manufacturers Ranitidine (Zantac) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ranitidine (Zantac)
2.9 Ranitidine (Zantac) Market Competitive Analysis
2.9.1 Ranitidine (Zantac) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ranitidine (Zantac) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranitidine (Zantac) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ranitidine Capsule
3.1.2 Ranitidine Oral Tablet
3.1.3 Ranitidine Injectable Solution
3.1.4 Ranitidine Oral Syrup
3.2 Global Ranitidine (Zantac) Sales Value by Type
3.2.1 Global Ranitidine (Zantac) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ranitidine (Zantac) Sales Value, by Type (2020-2031)
3.2.3 Global Ranitidine (Zantac) Sales Value, by Type (%) (2020-2031)
3.3 Global Ranitidine (Zantac) Sales Volume by Type
3.3.1 Global Ranitidine (Zantac) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ranitidine (Zantac) Sales Volume, by Type (2020-2031)
3.3.3 Global Ranitidine (Zantac) Sales Volume, by Type (%) (2020-2031)
3.4 Global Ranitidine (Zantac) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Ranitidine (Zantac) Sales Value by Application
4.2.1 Global Ranitidine (Zantac) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ranitidine (Zantac) Sales Value, by Application (2020-2031)
4.2.3 Global Ranitidine (Zantac) Sales Value, by Application (%) (2020-2031)
4.3 Global Ranitidine (Zantac) Sales Volume by Application
4.3.1 Global Ranitidine (Zantac) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ranitidine (Zantac) Sales Volume, by Application (2020-2031)
4.3.3 Global Ranitidine (Zantac) Sales Volume, by Application (%) (2020-2031)
4.4 Global Ranitidine (Zantac) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ranitidine (Zantac) Sales Value by Region
5.1.1 Global Ranitidine (Zantac) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ranitidine (Zantac) Sales Value by Region (2020-2025)
5.1.3 Global Ranitidine (Zantac) Sales Value by Region (2026-2031)
5.1.4 Global Ranitidine (Zantac) Sales Value by Region (%), (2020-2031)
5.2 Global Ranitidine (Zantac) Sales Volume by Region
5.2.1 Global Ranitidine (Zantac) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ranitidine (Zantac) Sales Volume by Region (2020-2025)
5.2.3 Global Ranitidine (Zantac) Sales Volume by Region (2026-2031)
5.2.4 Global Ranitidine (Zantac) Sales Volume by Region (%), (2020-2031)
5.3 Global Ranitidine (Zantac) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ranitidine (Zantac) Sales Value, 2020-2031
5.4.2 North America Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ranitidine (Zantac) Sales Value, 2020-2031
5.5.2 Europe Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ranitidine (Zantac) Sales Value, 2020-2031
5.6.2 Asia Pacific Ranitidine (Zantac) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ranitidine (Zantac) Sales Value, 2020-2031
5.7.2 South America Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ranitidine (Zantac) Sales Value, 2020-2031
5.8.2 Middle East & Africa Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ranitidine (Zantac) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ranitidine (Zantac) Sales Value
6.2.1 Key Countries/Regions Ranitidine (Zantac) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ranitidine (Zantac) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ranitidine (Zantac) Sales Value, 2020-2031
6.3.2 United States Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ranitidine (Zantac) Sales Value, 2020-2031
6.4.2 Europe Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ranitidine (Zantac) Sales Value, 2020-2031
6.5.2 China Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ranitidine (Zantac) Sales Value, 2020-2031
6.6.2 Japan Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ranitidine (Zantac) Sales Value, 2020-2031
6.7.2 South Korea Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ranitidine (Zantac) Sales Value, 2020-2031
6.8.2 Southeast Asia Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ranitidine (Zantac) Sales Value, 2020-2031
6.9.2 India Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ranitidine (Zantac) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Information
7.1.2 Sanofi-Aventis Introduction and Business Overview
7.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Offerings
7.1.5 Sanofi-Aventis Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Information
7.2.2 GlaxoSmithKline Introduction and Business Overview
7.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 GlaxoSmithKline Ranitidine (Zantac) Product Offerings
7.2.5 GlaxoSmithKline Recent Development
7.3 Hi-Tech Pharmacal Co.
7.3.1 Hi-Tech Pharmacal Co. Company Information
7.3.2 Hi-Tech Pharmacal Co. Introduction and Business Overview
7.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Offerings
7.3.5 Hi-Tech Pharmacal Co. Recent Development
7.4 Sun Pharma
7.4.1 Sun Pharma Company Information
7.4.2 Sun Pharma Introduction and Business Overview
7.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sun Pharma Ranitidine (Zantac) Product Offerings
7.4.5 Sun Pharma Recent Development
7.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
7.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Company Information
7.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Introduction and Business Overview
7.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Offerings
7.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
7.6 Dr. Reddy’s Laboratories Inc.
7.6.1 Dr. Reddy’s Laboratories Inc. Company Information
7.6.2 Dr. Reddy’s Laboratories Inc. Introduction and Business Overview
7.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Offerings
7.6.5 Dr. Reddy’s Laboratories Inc. Recent Development
7.7 Sandoz Inc. (part of Novartis AG)
7.7.1 Sandoz Inc. (part of Novartis AG) Company Information
7.7.2 Sandoz Inc. (part of Novartis AG) Introduction and Business Overview
7.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Offerings
7.7.5 Sandoz Inc. (part of Novartis AG) Recent Development
7.8 Strides (and Strides Arcolab international)
7.8.1 Strides (and Strides Arcolab international) Company Information
7.8.2 Strides (and Strides Arcolab international) Introduction and Business Overview
7.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Offerings
7.8.5 Strides (and Strides Arcolab international) Recent Development
7.9 Geri-Care Pharmaceuticals
7.9.1 Geri-Care Pharmaceuticals Company Information
7.9.2 Geri-Care Pharmaceuticals Introduction and Business Overview
7.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Offerings
7.9.5 Geri-Care Pharmaceuticals Recent Development
7.10 PAI Holdings, LLC
7.10.1 PAI Holdings, LLC Company Information
7.10.2 PAI Holdings, LLC Introduction and Business Overview
7.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 PAI Holdings, LLC Ranitidine (Zantac) Product Offerings
7.10.5 PAI Holdings, LLC Recent Development
7.11 Teva Pharmaceuticals
7.11.1 Teva Pharmaceuticals Company Information
7.11.2 Teva Pharmaceuticals Introduction and Business Overview
7.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Teva Pharmaceuticals Ranitidine (Zantac) Product Offerings
7.11.5 Teva Pharmaceuticals Recent Development
7.12 Granules Pharmaceuticals Inc.
7.12.1 Granules Pharmaceuticals Inc. Company Information
7.12.2 Granules Pharmaceuticals Inc. Introduction and Business Overview
7.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Offerings
7.12.5 Granules Pharmaceuticals Inc. Recent Development
7.13 Glenmark Pharmaceuticals (and Glenmark Generics)
7.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Company Information
7.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Introduction and Business Overview
7.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Offerings
7.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
7.14 Apotex Inc. (and Apotex Corporation)
7.14.1 Apotex Inc. (and Apotex Corporation) Company Information
7.14.2 Apotex Inc. (and Apotex Corporation) Introduction and Business Overview
7.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Offerings
7.14.5 Apotex Inc. (and Apotex Corporation) Recent Development
7.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
7.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Company Information
7.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Introduction and Business Overview
7.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Offerings
7.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
8 Industry Chain Analysis
8.1 Ranitidine (Zantac) Industrial Chain
8.2 Ranitidine (Zantac) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ranitidine (Zantac) Sales Model
8.5.2 Sales Channel
8.5.3 Ranitidine (Zantac) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Ranitidine (Zantac) Market Trends
Table 2. Ranitidine (Zantac) Market Drivers & Opportunity
Table 3. Ranitidine (Zantac) Market Challenges
Table 4. Ranitidine (Zantac) Market Restraints
Table 5. Global Ranitidine (Zantac) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Ranitidine (Zantac) Revenue Market Share by Company (2020-2025)
Table 7. Global Ranitidine (Zantac) Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Ranitidine (Zantac) Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Ranitidine (Zantac) Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Ranitidine (Zantac) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Ranitidine (Zantac) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Ranitidine (Zantac)
Table 13. Global Ranitidine (Zantac) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranitidine (Zantac) as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Ranitidine (Zantac) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Ranitidine (Zantac) Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Ranitidine (Zantac) Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Ranitidine (Zantac) Sales Market Share in Value by Type (2020-2025)
Table 20. Global Ranitidine (Zantac) Sales Market Share in Value by Type (2026-2031)
Table 21. Global Ranitidine (Zantac) Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Ranitidine (Zantac) Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Ranitidine (Zantac) Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Ranitidine (Zantac) Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Ranitidine (Zantac) Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Ranitidine (Zantac) Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Ranitidine (Zantac) Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Ranitidine (Zantac) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Ranitidine (Zantac) Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Ranitidine (Zantac) Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Ranitidine (Zantac) Sales Market Share in Value by Application (2020-2025)
Table 32. Global Ranitidine (Zantac) Sales Market Share in Value by Application (2026-2031)
Table 33. Global Ranitidine (Zantac) Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Ranitidine (Zantac) Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Ranitidine (Zantac) Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Ranitidine (Zantac) Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Ranitidine (Zantac) Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Ranitidine (Zantac) Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Ranitidine (Zantac) Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Ranitidine (Zantac) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Ranitidine (Zantac) Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Ranitidine (Zantac) Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Ranitidine (Zantac) Sales Value by Region (2020-2025) & (%)
Table 44. Global Ranitidine (Zantac) Sales Value by Region (2026-2031) & (%)
Table 45. Global Ranitidine (Zantac) Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Ranitidine (Zantac) Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Ranitidine (Zantac) Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Ranitidine (Zantac) Sales Volume by Region (2020-2025) & (%)
Table 49. Global Ranitidine (Zantac) Sales Volume by Region (2026-2031) & (%)
Table 50. Global Ranitidine (Zantac) Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Ranitidine (Zantac) Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Ranitidine (Zantac) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Ranitidine (Zantac) Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Ranitidine (Zantac) Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Ranitidine (Zantac) Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Ranitidine (Zantac) Sales Volume, (2026-2031) & (K Units)
Table 57. Sanofi-Aventis Company Information
Table 58. Sanofi-Aventis Introduction and Business Overview
Table 59. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Sanofi-Aventis Ranitidine (Zantac) Product Offerings
Table 61. Sanofi-Aventis Recent Development
Table 62. GlaxoSmithKline Company Information
Table 63. GlaxoSmithKline Introduction and Business Overview
Table 64. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Ranitidine (Zantac) Product Offerings
Table 66. GlaxoSmithKline Recent Development
Table 67. Hi-Tech Pharmacal Co. Company Information
Table 68. Hi-Tech Pharmacal Co. Introduction and Business Overview
Table 69. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Offerings
Table 71. Hi-Tech Pharmacal Co. Recent Development
Table 72. Sun Pharma Company Information
Table 73. Sun Pharma Introduction and Business Overview
Table 74. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sun Pharma Ranitidine (Zantac) Product Offerings
Table 76. Sun Pharma Recent Development
Table 77. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Company Information
Table 78. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Introduction and Business Overview
Table 79. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Offerings
Table 81. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
Table 82. Dr. Reddy’s Laboratories Inc. Company Information
Table 83. Dr. Reddy’s Laboratories Inc. Introduction and Business Overview
Table 84. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Offerings
Table 86. Dr. Reddy’s Laboratories Inc. Recent Development
Table 87. Sandoz Inc. (part of Novartis AG) Company Information
Table 88. Sandoz Inc. (part of Novartis AG) Introduction and Business Overview
Table 89. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Offerings
Table 91. Sandoz Inc. (part of Novartis AG) Recent Development
Table 92. Strides (and Strides Arcolab international) Company Information
Table 93. Strides (and Strides Arcolab international) Introduction and Business Overview
Table 94. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Offerings
Table 96. Strides (and Strides Arcolab international) Recent Development
Table 97. Geri-Care Pharmaceuticals Company Information
Table 98. Geri-Care Pharmaceuticals Introduction and Business Overview
Table 99. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Offerings
Table 101. Geri-Care Pharmaceuticals Recent Development
Table 102. PAI Holdings, LLC Company Information
Table 103. PAI Holdings, LLC Introduction and Business Overview
Table 104. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. PAI Holdings, LLC Ranitidine (Zantac) Product Offerings
Table 106. PAI Holdings, LLC Recent Development
Table 107. Teva Pharmaceuticals Company Information
Table 108. Teva Pharmaceuticals Introduction and Business Overview
Table 109. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Teva Pharmaceuticals Ranitidine (Zantac) Product Offerings
Table 111. Teva Pharmaceuticals Recent Development
Table 112. Granules Pharmaceuticals Inc. Company Information
Table 113. Granules Pharmaceuticals Inc. Introduction and Business Overview
Table 114. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Offerings
Table 116. Granules Pharmaceuticals Inc. Recent Development
Table 117. Glenmark Pharmaceuticals (and Glenmark Generics) Company Information
Table 118. Glenmark Pharmaceuticals (and Glenmark Generics) Introduction and Business Overview
Table 119. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Offerings
Table 121. Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
Table 122. Apotex Inc. (and Apotex Corporation) Company Information
Table 123. Apotex Inc. (and Apotex Corporation) Introduction and Business Overview
Table 124. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Offerings
Table 126. Apotex Inc. (and Apotex Corporation) Recent Development
Table 127. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Company Information
Table 128. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Introduction and Business Overview
Table 129. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Offerings
Table 131. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Ranitidine (Zantac) Downstream Customers
Table 135. Ranitidine (Zantac) Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Ranitidine (Zantac) Product Picture
Figure 2. Global Ranitidine (Zantac) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Ranitidine (Zantac) Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Ranitidine (Zantac) Sales Volume (2020-2031) & (K Units)
Figure 5. Global Ranitidine (Zantac) Sales Price (2020-2031) & (US$/Unit)
Figure 6. Ranitidine (Zantac) Report Years Considered
Figure 7. Global Ranitidine (Zantac) Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Ranitidine (Zantac) Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ranitidine (Zantac) Revenue in 2024
Figure 10. Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Ranitidine Capsule Picture
Figure 12. Ranitidine Oral Tablet Picture
Figure 13. Ranitidine Injectable Solution Picture
Figure 14. Ranitidine Oral Syrup Picture
Figure 15. Global Ranitidine (Zantac) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Ranitidine (Zantac) Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Ranitidine (Zantac) Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Ranitidine (Zantac) Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Ranitidine (Zantac) Price by Type (2020-2031) & (US$/Unit)
Figure 20. Product Picture of Hospital Pharmacy
Figure 21. Product Picture of Retail Pharmacy
Figure 22. Product Picture of Online Pharmacy
Figure 23. Global Ranitidine (Zantac) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Ranitidine (Zantac) Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Ranitidine (Zantac) Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Ranitidine (Zantac) Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Ranitidine (Zantac) Price by Application (2020-2031) & (US$/Unit)
Figure 28. North America Ranitidine (Zantac) Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Ranitidine (Zantac) Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Ranitidine (Zantac) Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Ranitidine (Zantac) Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Ranitidine (Zantac) Sales Volume (%), (2020-2031)
Figure 40. United States Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 46. China Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 48. China Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 58. India Ranitidine (Zantac) Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Ranitidine (Zantac) Sales Value by Type (%), 2024 VS 2031
Figure 60. India Ranitidine (Zantac) Sales Value by Application (%), 2024 VS 2031
Figure 61. Ranitidine (Zantac) Industrial Chain
Figure 62. Ranitidine (Zantac) Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
